Over half of patients diagnosed with acute myeloid leukemia (AML) are 65 years or older.
We examined patient characteristics, treatment patterns, and survival among elderly patients …

BACKGROUND Health care utilization in older adults (age≥ 60 years) with acute myeloid
leukemia (AML) has not been well studied. METHODS We conducted a retrospective …

Introduction Acute myeloid leukaemia (AML) is the most common type of leukaemia among
adults in the US. However, data on longitudinal treatment patterns and outcomes associated …

Background Acute myeloid leukemia is the second most common leukemia among United
States adults with a median age of 69 years. We investigated recent clinical practices related …

BACKGROUND: Acute myeloid leukemia (AML) is associated with a poor prognosis,
particularly in older patients. To the authors' knowledge, few population‐based studies of …

Acute myeloid leukemia (AML) is a disease of older adults, with a median age of 67 years at
presentation. In the past, only a third of older patients (defined as individuals older than 60 …

BACKGROUND Acute myeloid leukemia (AML) is the common form of acute leukemia in
adults, accounting for over 80% of all acute leukemias in individuals aged> 18 years. Overall …

Acute myeloid leukemia (AML) is a devastating disease, globally causing 85 000 deaths per
year in 2016, a number predicted to double in 2040, with years of life lost estimated to be 2.6 …

Acute myeloid leukemia (AML) is predominantly a disease of older adults, with a median
age at diagnosis of over 65 years. AML in older adults differs biologically and clinically from …

Acute myeloid leukemia (AML) in older patients presents a notable therapeutic challenge to
the clinical hematologist. The clinical biology of AML among patients is highly …